Literature DB >> 6016293

Hepatic effects of oral contraceptives.

R K Ockner, C S Davidson.   

Abstract

Mesh：

Substances：

Year:  1967        PMID： 6016293     DOI： 10.1056/NEJM196702092760607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.

Authors:  M A Sperling
Journal:  West J Med       Date:  1975-01

Review 2.  Hormonal steroid contraceptives. IV. Adverse reactions and management of the patient.

Authors:  E G McQueen
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Contraception with chlormadinone acetate in woman with previous contraceptive jaundice.

Authors:  R P Thompson; R Williams
Journal:  Br Med J       Date:  1970-01-17

4.  Oral contraceptives and the liver.

Authors: 
Journal:  Br Med J       Date:  1974-11-23

5.  Benign familial recurrent intrahepatic cholestasis.

Authors:  P B Lesser
Journal:  Am J Dig Dis       Date:  1973-04

6.  Hemangiomatosis of the liver with thrombosis following use of an oral contraceptive.

Authors:  R J Kositchek; R A Cullen
Journal:  Calif Med       Date:  1970-09

7.  Developments in jaundice.

Authors:  R P Thompson; R Williams
Journal:  Postgrad Med J       Date:  1969-03       Impact factor: 2.401

8.  Effect of chronic oral contraceptive steroids on theophylline disposition.

Authors:  K M Tornatore; R Kanarkowski; T L McCarthy; M J Gardner; A M Yurchak; W J Jusko
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Medical Staff Conference. Drug-induced liver disease.

Authors: 
Journal:  West J Med       Date:  1979-07

10.  Clinical evaluation of a new sequential oral contraceptive agent.

Authors:  L E Cowan
Journal:  Can Med Assoc J       Date:  1967-04-29       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.